Ralph Weichselbaum to Adverse Drug Reaction Reporting Systems
This is a "connection" page, showing publications Ralph Weichselbaum has written about Adverse Drug Reaction Reporting Systems.
Connection Strength
0.011
-
Clinical protocol. An open-label, phase I, dose-escalation study of tumor necrosis factor-alpha (TNFerade Biologic) gene transfer with radiation therapy for locally advanced, recurrent, or metastatic solid tumors. Hum Gene Ther. 2001 Jun 10; 12(9):1109-31.
Score: 0.011